A number of external and internal insults disrupt nucleolar structure, and the resulting nucleolar stress stabilizes and activates p53. We show here that nucleolar disruption induces acetylation and accumulation of p53 without phosphorylation. We identified three nucleolar proteins, MYBBP1A, RPL5, and RPL11, involved in p53 acetylation and accumulation. MYBBP1A was tethered to the nucleolus through nucleolar RNA. When rRNA transcription was suppressed by nucleolar stress, MYBBP1A translocated to the nucleoplasm and facilitated p53-p300 interaction to enhance p53 acetylation. We also found that RPL5 and RPL11 were required for rRNA export from the nucleolus. Depletion of RPL5 or RPL11 blocked rRNA export and counteracted reduction of nucleolar RNA levels caused by inhibition of rRNA transcription. As a result, RPL5 or RPL11 depletion inhibited MYBBP1A translocation and p53 activation. Our observations indicated that a dynamic equilibrium between RNA generation and export regulated nucleolar RNA content. Perturbation of this balance by nucleolar stress altered the nucleolar RNA content and modulated p53 activity.
Introduction
The tumour suppressor protein p53 responds to diverse stresses and regulates many target genes, the products of which induce cell-cycle arrest, apoptosis, senescence, and DNA repair (Levine, 1997; Prives and Hall, 1999) . In unstressed cells, p53 is maintained at low levels by its inhibitor HDM2, an ubiquitin ligase that ubiquitinates p53, thereby targeting the protein for proteasome-mediated degradation through a feedback mechanism (Michael and Oren, 2003; Brooks and Gu, 2006) . In response to various stresses, such as DNA damage or oncogene expression, p53 is stabilized and activated (Prives and Hall, 1999) .
DNA damage is widely believed to activate p53 as a transcription factor through post-translational modifications, such as phosphorylation, ubiquitination, and acetylation (Appella and Anderson, 2001; Brooks and Gu, 2003; Bode and Dong, 2004; Olsson et al, 2007; Vousden and Lane, 2007; Carter and Vousden, 2009; Kruse and Gu, 2009 ). Phosphorylation of p53 in response to DNA damage is mediated by several kinases (Bode and Dong, 2004; Olsson et al, 2007) and produces a number of downstream effects by changing the interaction between p53 and HDM2 or p300 (Shieh et al, 1997; Lambert et al, 1998; Chehab et al, 1999; Dumaz and Meek, 1999; Unger et al, 1999) . However, an accumulation of evidence has shown that the requirement for the aforementioned phosphorylation is probably not universal for p53 stabilization or activation (Ashcroft et al, 1999 (Ashcroft et al, , 2000 Blattner et al, 1999; Prives and Hall, 1999; Wu et al, 2002; Thompson et al, 2004) .
The p53 protein is acetylated at multiple lysine residues (Lys120, Lys164, Lys305, Lys320, Lys370, Lys372, Lys373, Lys381, Lys382, Lys386) by the p300/CBP complex, the p300/ CBP-associated factor (PCAF), or the Tip60 (Gu and Roeder, 1997; Sakaguchi et al, 1998; Tang et al, 2008) . Acetylation of p53 is sufficient to abrogate its ubiquitination by HDM2. There is a direct competition between acetylation and ubiquitination of the same C-terminal lysine residues in p53 (Li et al, 2002) . In addition, the acetylation of p53 enhances sequence-specific DNA binding of p53 (Gu and Roeder, 1997; Sakaguchi et al, 1998; Luo et al, 2004) and recruitment of a coactivator complex to promoter regions for activation of p53-targeted gene expression (Barlev et al, 2001) . Moreover, recent studies suggest that HDM2 represses transcription not only by mediating ubiquitination of p53, but also by forming a suppressor complex with p53 on the promoters of specific p53-responsive genes (Minsky and Oren, 2004; Arva et al, 2005; Ohkubo et al, 2006) . Acetylation blocks the interaction of p53 with HDM2 on DNA, which activates p53 regardless of its phosphorylation status. The p53-8KR mutant, in which the eight known acetylated sites are substituted with arginine, is unable to activate p21 and induce cell-cycle arrest and apoptosis . From these observations, p53 acetylation is believed to be indispensable for p53 activation. However, in a mouse model, the C-terminal lysine residues of p53 are not required for either stability or transactivation (Krummel et al, 2005) . Therefore, the contributions of acetylation at the C-terminus to p53 stability and transactivation may differ between mice and humans.
The p53 protein induces cell-cycle arrest or apoptosis under a wide variety of cellular stresses. However, it is not known how a single protein can integrate such a diversity of signals. Recently, a number of external and internal insults were shown to induce nucleolar stress by disrupting nucleolar structure (Rubbi and Milner, 2003; . Previous reports demonstrated that nucleolar disruption, induced by either anti-upstream binding factor (UBF) antibody microinjection or depletion of the transcription initiation factor-IA (TIF-IA), caused p53 stabilization (Rubbi and Milner, 2003; Yuan et al, 2005) . Thus, the existence of a stress sensor that monitors nucleolar structure and function and regulates p53 levels was proposed. Recent studies of the cellular response to nucleolar stress demonstrated that several nucleolar proteins, including nucleophosmin (NPM; also called B23), nucleolin (NCL; also called C23), nucleostemin (NS), ARF, and ribosomal proteins, such as RPL5, RPL11, RPL23, and RPS7, can bind to HDM2 and inhibit its activity towards p53 (Marechal et al, 1994; Kamijo et al, 1998; Pomerantz et al, 1998; Lohrum et al, 2003; Zhang et al, 2003; Dai et al, , 2008 Jin et al, 2004; Kurki et al, 2004; Saxena et al, 2006; Chen et al, 2007; Zhu et al, 2009) .
Here, we show that nucleolar disruption induces acetylation and accumulation of p53 without phosphorylation. We screened nucleolar proteins involved in acetylation and stabilization of p53 and identified Myb-binding protein 1a (MYBBP1A). Our results demonstrated that nucleolar disruption led to translocation of MYBBP1A from the nucleolus to the nucleoplasm. MYBBP1A then bound to p53 and facilitated binding between p53 and p300 to enhance p53-mediated transcription. We also found that knockdown of RPL5 and RPL11 significantly abrogated the accumulation and acetylation of p53 protein by inhibiting the translocation of MYBBP1A induced by nucleolar disruption.
Results
Nucleolar protein MYBBP1A is necessary for phosphorylation-independent p53 acetylation Phosphorylation of p53 at Ser15 enhances its acetylation by increasing the interaction with p300/CBP acetyltransferase (Lambert et al, 1998; Dumaz and Meek, 1999) . Recent reports, however, indicated that phosphorylation-independent p53 acetylation occurred during low-dose actinomycin D (ActD) treatment, which specifically inhibited RNA polymerase I-but not RNA polymerase II-driven transcription (Ashcroft et al, 2000; Ito et al, 2001; Tang et al, 2008) . In agreement with the reports, we observed that low-dose ActD treatment increased the p53 acetylation levels at Lys382 without inducing phosphorylation at Ser15 (Supplementary Figure S1A) in the MCF-7 cell line, which expresses wild-type p53. These results suggest that there may be pathways that induce acetylation of p53 in the absence of its phosphorylation at Ser15.
Recently, it was shown that activation of p53 was induced by nucleolar disruption, which also occurred during low-dose ActD treatment (Supplementary Figure S1B) (Rubbi and Milner, 2003; Yuan et al, 2005) . To test the relationship between Ser15 phosphorylation-independent p53 acetylation and nucleolar disruption, we induced nucleolar disruption by TIF-IA depletion. In agreement with previous reports, after TIF-IA siRNA treatment, nucleolar structure disappeared and translocation of the nucleolar marker protein NPM from the nucleolus to the nucleoplasm was observed in the MCF-7 and LNCaP cell lines, both of which express wild-type p53 (Supplementary Figures S2A and B, S3A and B) . Knockdown of TIF-IA induced the accumulation of p53 and elevated the acetylation levels at the lysine residues that were known to be acetylated by p300/CBP without phosphorylation at Ser15 (Figure 1A; Supplementary Figures S2C and D and S3C) . These results suggest that nucleolar disruption induces phosphorylation-independent acetylation of p53.
The acetylation levels of p53 have been shown to increase significantly in response to stress and correlate well with p53 activation and stabilization (Luo et al, 2000 (Luo et al, , 2001 Ito et al, 2001 Ito et al, , 2002 Vaziri et al, 2001; Knights et al, 2006; Li et al, 2007; Kim et al, 2008; Zhao et al, 2008 ). An accumulated body of evidence supports the conclusion that acetylation stabilizes p53 and is indispensable for p53 activation (Li et al, 2002; Tang et al, 2008) . Therefore, we searched for nucleolar proteins that could regulate p53 acetylation. Using a quantitative proteomics approach, Matthias Mann and coworkers characterized the flux of 489 endogenous nucleolar proteins, and found that nearly 300 proteins translocated from the nucleolus to the nucleoplasm following nucleolar disruption (Andersen et al, 2005) . Among these 300 proteins, we excluded 200 proteins based on their known function and selected 107 candidates for investigation. We generated a library of siRNAs against the mRNAs for these proteins (Supplementary Table S1 ) and examined the effects of each siRNA on both the acetylation status and quantity of p53 proteins in cells that had been treated with TIF-IA siRNA to increase p53 acetylation. As shown in Supplementary Figure  S4 , treatment of MCF-7 cells with siRNA against MYBBP1A, RPL5, or RPL11 reduced the protein levels and acetylation status of p53. RPL5 and RPL11 have been shown to be involved in the stabilization of p53 by binding to HDM2 and blocking its function (Lohrum et al, 2003; Zhang et al, 2003; . Thus, we first examined the function of MYBBP1A. MYBBP1A is a 160-kDa protein present mainly in the nucleolus (Tavner et al, 1998) . The role of MYBBP1A in the nucleolus was previously unknown. Immunostaining of cells with anti-MYBBP1A antibodies confirmed the nucleolar localization of MYBBP1A ( Figure 1B, upper panel) . TIF-IA depletion released MYBBP1A into the nucleoplasm ( Figure 1B , lower panel). To confirm that knockdown of MYBBP1A antagonized the acetylation of p53 proteins caused by nucleolar disruption, we evaluated the effects of MYBBP1A knockdown on p53 acetylation status when nucleolar disruption was triggered by siRNA for TIF-IA. As shown in Figure 1C , acetylation at Lys382 in p53, induced by nucleolar disruption, was significantly abrogated by MYBBP1A knockdown. MYBBP1A knockdown also decreased the acetylation levels at other lysine residues (Lys305 and Lys373) of p53 in MCF-7 and LNCaP cells ( Figure 1D ; Supplementary Figure S3D ) and partially counteracted the accumulation of p53 proteins induced by nucleolar disruption. The same result was obtained when a different siRNA for MYBBP1A (siMYBBP-2) was used ( Figure 1D ). Furthermore, MYBBP1A knockdown also reduced the acetylation levels of p53 during low-dose ActD treatment ( Figure 1E ).
To confirm that MYBBP1A was involved in the acetylation of p53 caused by nucleolar disruption, we performed a rescue experiment. An expression plasmid containing p53 was transfected into p53-deficient H1299 cells ( Figure 1F ).
Western blot analysis measured the basal expression and acetylation levels of p53 in p53-transfected H1299 cells without stress. TIF-IA depletion induced p53 acetylation that was reduced by treatment with siRNA for MYBBP1A ( Figure 1F ). The reduction of p53 acetylation by MYBBP1A siRNA was recovered by coexpression of mutated MYBBP1A (MYBBP1A-simut), which was not downregulated by the siRNA for MYBBP1A ( Figure 1F ), demonstrating that MYBBP1A was necessary for the efficient acetylation of p53 protein under nucleolar disruption.
We next evaluated the contributions of MYBBP1A to p53 acetylation induced by DNA-damaging stress, resulting from exposure to adriamycin (ADR), UV light, or high-dose ActD. These stresses are known to induce nucleolar disruption (Rubbi and Milner, 2003) , translocation of MYBBP1A into the nucleoplasm (Yamauchi et al, 2008) , and p53 modifications, including phosphorylation and acetylation (Shieh et al, 1997; Tibbetts et al, 1999; Ito et al, 2001; Saito et al, 2003) . Depletion of MYBBP1A did not alter phosphorylation but did reduce the acetylation levels of p53 (Supplementary Figure  S5) . The reduction of p53 acetylation by MYBBP1A depletion was more significant in cells treated with TIF-IA siRNA than in those treated with DNA-damaging agents. Thus, our results indicated that while MYBBP1A was also involved in the DNA damage-induced acetylation of p53, its contribution to p53 acetylation was higher in cells subjected to TIF-IA depletion than in cells subjected to DNA damage.
MYBBP1A increases the binding of p300 to p53
To investigate the molecular basis for the functions of MYBBP1A, the interaction between MYBBP1A and p53 was first investigated. Coimmunoprecipitation experiments revealed binding of endogenous MYBBP1A to p53 in MCF-7 cells under nucleolar stress conditions (Figure 2A ). GST pulldown experiments showed that MYBBP1A directly bound to the C-terminal 34 amino-acid region of p53, which contains six lysine residues that are acetylated by p300/CBP ( Figure 2B ).
Because MYBBP1A is required for effective acetylation at p300/CBP-mediated acetylation sites in p53, the interactions among p53, MYBBP1A, and p300 were investigated next ( Figure 2C ). Nuclear extracts derived from MCF-7 cells treated with TIF-IA siRNA were prepared for this purpose. Proteins in the extracts were sequentially immunoprecipitated with anti-MYBBP1A and anti-p300 antibodies. Immunoblot analysis demonstrated the presence of p53 in the final immunoprecipitant, indicating that p53 formed a ternary complex with MYBBP1A and p300 in the TIF-IA siRNA-treated cells ( Figure 2C ).
We next tested the effects of MYBBP1A on the interaction between p53 and p300. p53 and p300 expression plasmids were introduced into H1299 cells with or without the MYBBP1A expression plasmid. Coimmunoprecipitation experiments showed that the association of p53 with p300 was significantly enhanced by MYBBP1A expression in the presence of ADR ( Figure 2D ). Conversely, knockdown of MYBBP1A in MCF-7 cells abrogated the nucleolar disruption-induced binding between p53 and p300 ( Figure 2E ). In contrast, the binding of p53 to PCAF and Tip60, both of which are known to be histone acetyltransferases for p53, was not enhanced by MYBBP1A ( Figure 2D ). These results indicated that MYBBP1A selectively stabilized the binding between p53 and p300.
Knockdown of MYBBP1A decreases the transactivating capabilities of p53
Our results indicated that MYBBP1A enhanced the binding between p300 and p53 and increased p53 acetylation levels. p300 also functions as a coactivator for p53 by acetylating histones and enhancing the transcription of p53-target genes. Thus, we investigated the recruitment of p53 and p300 to the promoter region of the p21 gene by a chromatin immunoprecipitation (ChIP) assay. As shown in Figure 3A and
Supplementary Figure S6A , treatment of cells with TIF-IA siRNA, ADR, or ActD enhanced the recruitment of p53 and p300 to the p21 promoter. The recruitment of p53 and p300 was abrogated by knockdown of MYBBP1A ( Figure 3A ; Supplementary Figure S6A) .
The effects of MYBBP1A on the induction levels of p53-target gene products were examined. Consistent with the results obtained from ChIP analysis, depletion of TIF-IA increased the mRNA and protein levels of p21, HDM2, and PUMA in MCF-7 and LNCaP cells (Figure 3B and C; Supplementary Figure S3E ). The elevation of these mRNA and protein levels was impaired in cells in which MYBBP1A was knocked down by siRNA (Figure 3B and C; Supplementary Figure S3E ). Low-dose ActD treatment also increased p21 protein levels ( Figure 3D ), which were also reduced by MYBBP1A siRNA treatment ( Figure 3D ). Similar results were observed for ADR and high-dose ActD treatments (Supplementary Figure S6B) .
To confirm that the activation of p53 by MYBBP1A was mediated by p53 acetylation, we constructed a p53 acetylation-deficient mutant, p53-KR(p300). This mutant contained eight amino-acid substitutions (K164R, K305R, K370R, K372R, K373R, K381R, K382R, and K386R) at the lysine residues (Supplementary Figure S7A) , which were not acetylated by p300. Introduction of these substitutions did not reduce the interaction between MYBBP1A and p53 (Supplementary Figure S7B ). To test the effects of MYBBP1A expression 35 S-labelled MYBBP1A was incubated with the GST-fused full-length or truncated p53 proteins. After extensive washing, bound proteins were analysed by SDS-PAGE and autoradiography. (C) MYBBP1A forms a ternary complex with p53 and p300. MCF-7 cells were treated with siTIF-IA for 48 h. The cell lysates were sequentially immunoprecipitated with anti-MYBBP1A and anti-p300 antibodies, and immunoprecipitates were detected by immunoblot using antibodies against MYBBP1A, p53, and p300. (D) MYBBP1A increases the binding of p300, but not PCAF and Tip60, to p53. H1299 cells were transfected with expression vectors for FLAG-p300, FLAG-PCAF, FLAGTip60, MYBBP1A, and Myc-p53 as indicated. Twenty-four hours after transfection, the cells were treated with ADR (0.5 mg/ml) for 12 h to induce nucleolar disruption. FLAG-p300, FLAG-PCAF, and FLAG-Tip60 were immunoprecipitated using anti-FLAG antibodies, and the immunoprecipitates were eluted using FLAG peptides, then analysed by immunoblot using antibodies against FLAG and p53. HAT, histone acetyltransferases. (E) Knockdown of MYBBP1A decreases the binding of p300 to p53. MCF-7 cells were treated with siCont or siMYBBP with or without siTIF-IA for 48 h. The cell lysates were prepared, immunoprecipitated with normal rabbit IgG or anti-p300 antibodies, and analysed by immunoblot using antibodies against MYBBP1A, p53, and p300. on p53 acetylation and p53-target gene expression, an expression plasmid containing wild-type p53 or p53-KR(p300) was introduced into the H1299 cells ( Figure 3E ). Exogenously expressed wild-type p53 was acetylated, and protein levels of p21 and PUMA were found to increase ( Figure 3E ). Expression of MYBBP1A with wild-type p53 enhanced p53 acetylation and further increased the protein levels of p21 and PUMA ( Figure 3E ). In contrast, expression of MYBBP1A with p53-KR(p300) neither changed the acetylation status of p53-KR(p300) nor potentiated the elevation of p21 and PUMA ( Figure 3E ). These results support our model that MYBBP1A enhanced transcriptional activity of p53 by increasing p53 acetylation by p300.
We next investigated the effects of MYBBP1A knockdown on nucleolar disruption-induced apoptosis. In agreement with previous results, treatment of MCF-7 or LNCaP cells with siRNA for TIF-IA increased the number of dead cells ( Figure 3F ; Supplementary Figure S3F ) and cell death caused by TIF-IA knockdown was dependent on the presence of p53 (Supplementary Figure S8) . Cell death induced by TIF-IA Figure 3F; Supplementary Figure S3F ). The contribution of MYBBP1A to apoptosis induced by ADR or ActD treatment was evaluated. These stresses increased the number of dead cells (Supplementary Figure S6C) . Depletion of MYBBP1A decreased the number of dead cells (Supplementary Figure S6C) , indicating that MYBBP1A was also involved in cell death induced by ADR and ActD treatment. Consistent with the results shown in Figure 1 and Supplementary Figure S5 , MYBBP1A depletion had a greater affect on p53-mediated responses in cells treated with TIF-IA siRNA than in those treated with DNA-damaging agents.
MYBBP1A is anchored in the nucleolus through binding to nucleolar RNA
To further investigate the function of MYBBP1A, a protein complex containing MYBBP1A was purified. We generated MCF-7 cells that stably expressed FLAG-tagged MYBBP1A. Nucleolar extract fractions were then prepared from these cells, and the protein complexes, including FLAG-MYBBP1A, were precipitated using anti-FLAG antibody-conjugated M2-agarose beads. The MYBBP1A-interacting proteins were identified by mass spectrometry as NOL1, DHX15, p68, YB-1, NPM, and EBP2 ( Figure 4A ).
Some of these proteins are known to be involved in rRNA processing and are capable of RNA binding (Gustafson et al, 1998; Gonda et al, 2006; Grisendi et al, 2006; Fukuda et al, 2007; Hirano et al, 2009) , whereas MYBBP1A does not contain obvious candidate RNA-binding domains. These results, together with the observation that suppression of rRNA gene transcription induced translocation of MYBBP1A from the nucleolus, suggested that MYBBP1A may indirectly bind to RNA as part of an RNA-binding complex and may be anchored to the nucleolus through RNA. To test this possibility, MCF-7 cells were permiabilized and incubated with RNase. As shown in Figure 4B , RNase treatment did not affect the localization of UBF, which directly bound to the rDNA promoter region; however, the treatment caused translocation of MYBBP1A and NPM from the nucleolus to the nucleoplasm ( Figure 4B ). These results indicated that RNA acted as a scaffold for MYBBP1A and NPM. Taken together, our results suggested that reduction of rRNA production through inhibition of rRNA gene transcription decreased the MYBBP1A scaffold in the nucleolus and caused its translocation from the nucleolus to the nucleoplasm. RPL5 and RPL11 are necessary for MYBBP1A transport from the nucleolus to the nucleoplasm Using an siRNA library against nucleolar proteins, we found that three gene products, MYBBP1A, RPL5, and RPL11, were involved in p53 accumulation and acetylation (Supplementary Figure S4 ). Depletion of MYBBP1A, RPL5, or RPL11 reduced both the protein levels and the acetylation status of p53, which had been elevated by TIF-IA knockdown ( Figure 5A ). Reductions in the protein levels and acetylation status of p53 were more effective by RPL5 or RPL11 knockdown than by MYBBP1A knockdown ( Figure 5A ). To investigate the relationships among MYBBP1A, RPL5, and RPL11, MYBBP1A was knocked down together with either RPL5 or RPL11. Treatment of cells with siRNAs for MYBBP1A and RPL5 or for MYBBP1A and RPL11 did not result in additive effects on the protein or acetylation levels of p53, which had been reduced by RPL5 or RPL11 siRNA ( Figure 5A ). These results suggested that RPL5 and RPL11 are positioned upstream of MYBBP1A in the pathway that regulates p53 accumulation and acetylation.
It is well known that RPL5 and RPL11 stabilize p53 by binding to HDM2 and blocking its function. Knockdown of HDM2 partially recovered the reductions in p53 protein and acetylation levels caused by RPL5 or RPL11 knockdown ( Figure 5B , compare lanes 2 and 3, respectively, with lanes 5 and 6). These results confirmed the involvement of HDM2 in p53 regulation by RPLs. However, the partial HDM2-mediated recovery of reductions in p53 accumulation and acetylation induced by RPL5 or RPL11 knockdown suggested the presence of an HDM2-independent pathway for p53 activation. Therefore, we examined the effects of RPL5 or RPL11 siRNAs on MYBBP1A localization. Immunostaining showed that TIF-IA depletion caused translocation of both MYBBP1A and NPM from the nucleolus to the nucleoplasm in MCF-7 and LNCaP cells ( Figure 5C ; Supplementary Figure  S9) . Surprisingly, while MYBBP1A depletion did not affect the localization of NPM, knockdown of RPL5 or RPL11 significantly inhibited MYBBP1A and NPM translocation from the nucleolus to the nucleoplasm, which had been induced by TIF-IA knockdown ( Figure 5C; Supplementary Figure S9) . Depletion of RPL5 or RPL11 also abrogated the ADR and ActD-induced translocation of MYBBP1A into the nucleoplasm (Supplementary Figure S10) . In contrast, knockdown of RPL23 or RPL26 could not inhibit the translocation of MYBBP1A and NPM induced by nucleolar disruption (Supplementary Figure S11) .
These observations, together with the results showing that MYBBP1A and NPM were anchored to the nucleolus through RNA, suggested that the nucleolar RNA content could be retained by RPL5 or RPL11 depletion, even when rRNA transcription was abrogated by TIF-IA depletion. Thus, we purified the nucleolus from cells treated with a combination of the siRNAs indicated in Figure 6A and determined the nucleolar RNA content. As shown in Figure 6A , TIF-IA depletion decreased the content of both the total and 28S rRNA in the nucleolus. MYBBP1A knockdown did not affect the reduction of nucleolar RNA content induced by TIF-IA depletion ( Figure 6A ). In agreement with our hypothesis, knockdown of RPL5 or RPL11 increased the RNA content in the nucleolus and maintained high RNA levels, even when the cells were treated with TIF-IA siRNA ( Figure 6A ). We also found that the nucleoli in RPL5 or RPL11 siRNA-treated cells appeared to be larger than those in the control siRNA-treated cells. This result may reflect an increase in nucleolar RNA content in RPL5 or RPL11-depleted cells ( Figure 6A ). The same result was obtained when cells were treated with ADR (Supplementary Figure S12) .
Because knockdown of RPL5 or RPL11 abrogates the reduction of nucleolar RNA content induced by TIF-IA depletion, we first hypothesized that knockdown of RPL5 or RPL11 counteracted the suppression of rRNA transcription caused by TIF-IA depletion. To test this, we performed nuclear runon assays ( Figure 6B ). The results showed that the treatment of cells with TIF-IA siRNA significantly suppressed the transcription of rRNA genes, and this suppression was not restored by knockdown of RPL5 or RPL11 ( Figure 6B ). These results indicated that retention of nucleolar RNA content by RPL5 or RPL11 depletion was not due to the recovery of rRNA transcription.
Recently, it was reported that rpL5 and rpL11, orthologs of mammalian RPL5 and RPL11, were required for export of pre-ribosomes with rRNA in Saccharomyces cerevisiae . Therefore, we next examined the effects of RPL5 or RPL11 knockdown on rRNA transport. We labelled newly synthesized rRNA in MCF-7 cells with BrUTP in the presence of a-amanitin, which specifically inhibits RNA polymerase II. These cells were then cultured in a BrUTP-free chase medium. The localization of labelled RNA was determined by immunostaining using anti-BrdU antibodies at the time points indicated in Figure 6C . At the beginning of the chase (0 min), the labelled RNA was located in the nucleolus in each siRNA-treated cell. After 60 min incubation, the labelled RNA was exported into the nucleoplasm in the control or MYBBP1A siRNA-treated cells; however, the labelled RNA was retained in the nucleolus in RPL5 or RPL11-depleted cells ( Figure 6C ). These results indicated that RPL5 and RPL11 were necessary for RNA transport from the nucleolus in mammalian cells. Knockdown of RPL5 or RPL11 inhibited rRNA transport from the nucleolus and counteracted the reduction of RNA levels in the nucleolus that had been induced by inhibition of rRNA transcription ( Figure 6C) . As a result, RPL5 or RPL11 knockdown inhibited MYBBP1A translocation.
Our observations indicated that the nucleolar RNA content was maintained by a dynamic equilibrium between RNA generation and export. The loss of this balance due to stress altered the nucleolar RNA content and modulated p53 activity.
Discussion
DNA damage has been shown to induce phosphorylation at multiple serine residues, including Ser15, in p53 (Siliciano et al, 1997; Ashcroft et al, 1999 Ashcroft et al, , 2000 . Phosphorylation of p53 was shown to enhance its ability to interact with p300/ CBP, thereby enhancing p53 acetylation (Lambert et al, 1998; Dumaz and Meek, 1999) . As loss of acetylation completely abolishes p53-dependent growth arrest and apoptosis, acetylation of p53 is an indispensable event for p53 activation ).
Grummt's group showed that nucleolar disruption was sufficient for induction of p53-dependent apoptosis without DNA damage (Yuan et al, 2005) . The nucleolar disruption did not enhance p53 phosphorylation, but instead induced its acetylation. Our observations indicated that disruption of the nucleolus led to translocation of the nucleolar protein MYBBP1A into the nucleoplasm. MYBBP1A then bound to the C-terminus of p53 and stabilized binding between p53 and p300. As a result, MYBBP1A enhanced acetylation of p53 and increased its transcriptional activity. Several nucleolar proteins, including RPL5, RPL11, RPL23, NPM, NCL, NS, and ARF, are known to be involved in the stabilization of p53 proteins. Ribosomal proteins RPL5, RPL11, and RPL23, which are usually assembled into the 60S ribosome subunit and exported to the rough endoplasmic reticulum for protein synthesis, have been identified as proteins that directly bind to HDM2 and inhibit HDM2-mediated p53 ubiquitination (Marechal et al, 1994; Lohrum et al, 2003; Zhang et al, 2003; Jin et al, 2004) . Likewise, the nucleolar proteins NPM, NCL, NS, and ARF also directly bind to HDM2 and inhibit p53 ubiquitination (Kamijo et al, 1998; Pomerantz et al, 1998; Kurki et al, 2004; Saxena et al, 2006; Dai et al, 2008) . Thus, the mode of action of MYBBP1A was found to be different from those of RPLs, NPM, NCL, NS, or ARF. In contrast to these nucleolar proteins, MYBBP1A directly binds to the C-terminus of p53 and enhances its acetylation. In a mouse model, the C-terminal lysine residues of p53 are not required for either stability or transactivation (Krummel et al, 2005) . On the other hand, many biochemical and human cell line studies suggest that p53 acetylation at the C-terminus stabilizes p53 and activates its transcriptional activity. MYBBP1A is also regulated differently in mice and humans. Mouse Mybbp1a was processed to a short form by ActD treatment (Yamauchi et al, 2008) , although human MYBBP1A was not (data not shown). Therefore, the mechanisms of p53 activation by MYBBP1A may differ between species.
Our results indicated that MYBBP1A binds to the C-terminus of p53. An accumulation of evidence supports the suggestion that the core domain and C terminus may be the docking sites for several p53 coactivators, such as ASPPs, hCAS/CSE1L, HZF, MUC1, and YB-1, which are all critically involved in the induction of different targets by p53 (Takenaka et al, 1995; Samuels-Lev et al, 2001; Homer et al, 2005; Wei et al, 2005; Trigiante and Lu, 2006; Das et al, 2007; Tanaka et al, 2007; Kruse and Gu, 2009; Tian et al, 2009; Vousden and Prives, 2009) . Considering that MYBBP1A complex contains YB-1, MYBBP1A may also be involved in the selective recruitment of these coactivators to the promoter regions of p53-target genes. Some studies suggest that MYBBP1A has a role in RNA polymerase II-dependent transcription regulation. It has been shown to bind to the transcription factors c-Myb, c-Jun, aryl hydrocarbon receptor, PPARg coactivator 1a (PGC-1a), the RelA/p65 subunit of NF-kB, Prep1, and mCRY1 (Favier and Gonda, 1994; Tavner et al, 1998; Jones et al, 2002; Fan et al, 2004; Diaz et al, 2007; Owen et al, 2007; Hara et al, 2009) , although the influence of MYBBP1A on transcription was variable. Considering these reports together with our results, MYBBP1A may provide a physical signalling link between RNA polymerase II-dependent transcription and nucleolar function.
It is thought that RNA polymerase I-driven transcription is responsible for the maintenance of the steady-state nucleolar structure (Schwarzacher and Wachtler, 1993; Scheer and Hock, 1999) . Indeed, transcriptional inhibition of RNA polymerase I by TIF-IA depletion or DNA-damaging agents led to dissociation of several nucleolar proteins, including a nucleolar marker NPM and MYBBP1A from the nucleolus ( Figure 5C ; Supplementary Figure S10 ) (Rubbi and Milner, 2003; Yuan et al, 2005; Yamauchi et al, 2008) . In our experiment, we found that MYBBP1A associated with several rRNA processing proteins that possessed RNA-binding abilities. RNase treatment of the cells caused dissociation of MYBBP1A as well as NPM from the nucleolus. Knockdown of RPL5 or RPL11 retained the RNA content in the nucleolus and inhibited the translocation of MYBBP1A and NPM from the nucleolus to the nucleoplasm, even when rRNA transcription was stopped by TIF-IA depletion. These observations imply that the presence of nucleolar RNA, not the RNA polymerase I-driven transcription, was responsible for maintenance of the nucleolar structure.
A previous report showed that in Xenopus laevis, the recruitment of rRNA processing proteins to the nucleolus was dependent on the presence of pre-rRNAs but not on RNA polymerase I-dependent transcription In human cell lines, it was demonstrated that pre-rRNA was predominantly synthesized near the G2/M transition. The synthesized pre-rRNA persisted throughout mitosis and participated in the assembly of the daughter cell nucleolus by recruiting rRNA processing complexes. This recruitment was independent of RNA polymerase I-driven transcription (Dousset et al, 2000) . Gonda et al (2003 Gonda et al ( , 2006 showed that nucleolar disruption was induced by the specific intrinsic proteins FRGY2a and FRGY2b, both of which contained RNP1-like and RNP2-like RNA-binding motifs, under conditions in which RNA polymerase I transcription in X. laevis was ongoing. These findings were consistent with our model that nucleolar RNA content, rather than RNA polymerase I-dependent transcription, was important for maintaining nucleolar structure.
The siRNA library screen showed that depletion of RPL5 or RPL11 significantly abrogated the accumulation and acetylation of p53. Vousden's and other groups have demonstrated that RPL5 and RPL11 bind to the central acidic regions of HDM2, and inhibit the HDM2 E3 ligase activity towards p53 protein (Lohrum et al, 2003; Zhang et al, 2003; Lindstrom et al, 2007; Horn and Vousden, 2008) . Depletion of either RPL5 or RPL11 significantly impeded the stabilization of p53 in response to ribosomal stress, and enforced expression of RPL5 or RPL11 resulted in p53-dependent cell-cycle arrest (Lohrum et al, 2003; Zhang et al, 2003; Bhat et al, 2004; . In agreement with these reports, we also found that depletion of RPL5 or RPL11 was more effective at inhibiting p53 accumulation than was depletion of MYBBP1A. In addition to these functions, we found that RPL5 and RPL11 were necessary for RNA export from the nucleolus to the nucleoplasm. Our results demonstrated that knockdown of RPL5 or RPL11 downregulated rRNA transport and retained RNA in the nucleolus after suppression of rRNA transcription. As a result, RPL5 or RPL11 knockdown inhibited MYBBP1A translocation. RPL5 and RPL11 are reportedly components of the 5S rRNA-protein complex (Spierer and Zimmermann, 1978; Steitz et al, 1988; Nariai et al, 2005; Zhang et al, 2007; Horn and Vousden, 2008) . Incorporation of this complex into pre-ribosomes is an important step in the assembly of 60S ribosomal subunits (Van Ryk et al, 1992; Dechampesme et al, 1999) . RPL5 and RPL11 are essential for the incorporation step of the 5S rRNA complex into pre-ribosomes . It is predicted from our results that incorporation of 5S rRNA into pre-ribosomes may be an essential step for rRNA transport from the nucleolus.
Our observations indicated that nucleolar RNA content is maintained by its generation and export. The loss of balance between RNA generation and export due to stress alters nucleolar RNA content and modulates p53 activity. When the nucleolar RNA content was reduced, MYBBP1A and RPLs were released from the nucleolus, an event that subsequently enhanced p53 activity (Figure 7 ).
Materials and methods
Cell culture and treatments MCF-7 human breast cancer cells, LNCaP human prostate cancer cells, H1299 p53-deficient human lung cancer cells were maintained in DMEM (Sigma). All media were supplemented with 10% fetal bovine serum and penicillin-streptomycin mixed solution (Nacalai tesque). Cells were maintained at 371C in an atmosphere containing 5% CO 2 and 100% humidity. DNA damage was induced by ADR (0.5 mg/ml), UV irradiation (25 J/m 2 ), or ActD (40 nM).
siRNA and plasmid DNA transfection For transfection of siRNAs, cells at 30-50% confluency were transfected with 20 nM of siRNA using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's protocol. Protein and RNA were extracted at 48 h after transfection of siRNA. For transfection of plasmid DNA, cells at 70-80% confluency were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Protein was extracted at 24 h after transfection of plasmid DNA.
Immunoprecipitation
To monitor the interaction of MYBBP1A, p300, PCAF, Tip60, and p53 in vivo, H1299 cells were transfected with expression vectors encoding the respective proteins (pcDNA3-HA-MYBBP1A, pcDNA3-FLAG-p300, pcDNA3-FLAG-PCAF, pcDNA3-FLAG-Tip60, and pcDNA3-Myc-p53). Twenty-four hours after transfection, cells were lysed in TNE buffer (20 mM Tris-HCl at pH 7.5, 150 mM NaCl, 2 mM EDTA, and 1% NP-40) at 41C for 30 min. The cleared lysates were incubated for 2 h with 10 ml of anti-FLAG M2-agarose beads. After washing four times with the same buffer, FLAG-tagged proteins were eluted with 0.25 mg/ml of FLAG peptide in TNE buffer at 41C for 30 min, separated on 7.5% SDS-polyacrylamide gels, and analysed by immunoblotting with indicated antibodies. For coimmunoprecipitation of the endogenous proteins, MCF-7 cells were lysed in TNE buffer at 41C for 30 min. The cleared lysate was incubated for 4 h with 2 mg of antibodies against the indicated proteins, 10 ml of protein G sepharose was added, and the sample was rotated for 1 h at 41C. After washing four times with the same buffer, immunoprecipitates were separated on 7.5% SDS-polyacrylamide gels, and analysed by immunoblotting with the indicated antibodies. For detection of a ternary complex consisting of MYBBP1A, p53, and p300, MCF-7 cells were treated with TIF-IA siRNA for 48 h. The cell lysates were first immunoprecipitated with anti-MYBBP1A antibody and eluted from the beads using the peptide with raised anti-MYBBP1A antibody. The eluted sample was sequentially immunoprecipitated using anti-p300 antibody, and immunoprecipitates were detected by immunoblotting using antibodies against MYBBP1A, p53, and p300.
Chromatin immunoprecipitation
ChIP assays were performed as described Sinkkonen et al, 2005; Saramaki et al, 2006 ) with a minor modification. Anti-p53 (FL393) or anti-p300 (N-15) antibody (Santa Cruz Biotechnology) was used for immunoprecipitation. Real-time PCR was performed using the Thermal Cycler Dice TM TP800 (Takara) and SYBER Premix Ex Taq (Takara). The primers for realtime PCR were as follows: 5 0 -GTGGCTCTGATTGGCTTTCTG-3 0 and 5 0 -CTGAAAACAGGCAGCCCAAG-3 0 for p21-p53RE.
RNase treatment
Cells grown on chamber slides were permeabilized with 0.1% Triton X-100 in PBS, washed with PBS, and treated for 10 min with RNase A (1 mg/ml). After washing, cells were fixed 3.7% formaldehyde in PBS for 10 min and immunofluorescence analysis was performed.
Nucleoli purification and quantitative determination of RNA content Nucleoli were isolated from 1.2 Â10 7 MCF-7 cells in high purity by density gradient fractionation as previously described (Andersen et al, 2005) . Total RNA was prepared from the isolated nucleoli and quantified by spectrophotometry. 28S rRNA levels were determined by RT-qPCR and normalized to DNA content, which was determined by qPCR for p21 promoter region (p21-p53RE) using the nuclear fraction.
Pulse-chase analysis
Pulse-chase analysis was performed as previously described (Thiry et al, 2008) . Briefly, cells were grown on chamber slides and pretreated with 20 mg/ml a-amanitin for 2 h 30 min. The BrUTPFuGENE HD complexes were prepared by mixing 5 mM BrUTP (Sigma) and FuGENE HD (Roche) and incubated for 15 min. Then, the complexes were added to the cells for 15 min at 371C. After this pulse, the complexes were removed and the cells were either directly fixed or incubated in the BrUTP-free medium containing 10 mg/ml a-amanitin for 60 min at 371C. The labelled RNA was analysed by immunofluorescence using anti-BrdU antibody.
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